Health

BAT is vying to become a leader in the on-the-go wellbeing and stimulation space through a new corporate venturing unit that has been quietly investing in the space since last summer.

German Media Pool was among the participants in a $44.2m round that will fund the building of the cannabinoid product developer's production and research facility.

Gene therapy startup VectorY has raised more than $37m in an Eli Lilly-backed seed round while AR helmet developer XYZ Reality pulled in over $28m.

Morningside Venture Investments has led a series B round for the fibrotic diseases-focused spinout that advances University of Strasbourg research.

The Alibaba Health-backed medical data technology and services provider has chosen the US for its planned initial public offering.

The cancer and autoimmune disease drug developer completed a Legend Star-backed series D round led by Mirae Asset Financial Group.

Cold Spring Harbor Laboratory will work with Autobahn Labs to propel more early-stage discovery programmes into spinouts.

The pregnancy biomarker test provider plans to float on the Nasdaq Global Market having raised $220m in funding from investors including LabCorp and Anthem.

Ohio State University has again thrown its weight behind Rev1 Ventures, whose latest fund also attracted University of Dayton and multiple corporates.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Keio spinout Heartseed has added $37m to its coffers thanks to the university's Innovation Initiative and UTokyo Innovation Platform.